Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

Ruth E Farmer; Deborah Ford; Harriet J Forbes ORCID logo; Nishi Chaturvedi; Richard Kaplan; Liam Smeeth ORCID logo; Krishnan Bhaskaran ORCID logo; (2017) Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 46 (2). 745-. ISSN 0300-5771 DOI: 10.1093/ije/dyx046
Copy

The reported hazard ratios for two of the 46 papers included in this systematic review were incorrect. The estimates from Currie et al (2009) (reference 3) and Currie et al (2013) (reference 47) should have been inverted. This error affected some of the results reported in the abstract and the main text; the relevant data points on Figures 2, 3 and 4 and in the supplementary table; some of the data in Table 4; and one sentence in the discussion. All these items have now been corrected. The key results and conclusions were unaffected by this error.


picture_as_pdf
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads